Certificate of Analysis (COA)
Compound identity, lot reference, purity/assay fields and QC sign-off fields for the production lot for the selected current batch.
In-house production & QC · batch documentation support for the production lot
Pepti provides COA, HPLC purity data, MS identity data and lot traceability for qualified B2B procurement. The applicable document set is connected to the selected compound and lot during RFQ review, with independent testing options for buyers who need an additional verification layer.
Sample document pack
Ask for a redacted sample COA format or a current-lot document review. Pepti provides batch-linked COA, HPLC chromatogram and MS identity documentation and aligns the applicable files with the selected compounds during RFQ review.
Compound identity, lot reference, purity/assay fields and QC sign-off fields for the production lot for the selected current batch.
HPLC chromatogram support is confirmed by compound and current batch for the production lot, especially for higher-value RFQs.
MS identity file support is confirmed by compound and current batch for the production lot.
Representative analytical previews
These protected previews show representative historical analytical results from previously tested Retatrutide samples, including HPLC-UV purity, LC-MS identity confirmation and measured net content. They demonstrate the analytical format and testing capability; they are not current-batch COAs and do not represent every production lot.
Full-resolution analytical files, report identifiers and applicable batch documents are not published as reusable downloads. Qualified buyers can request the relevant document review privately. A historical preview is reference material only; buyers who require additional confidence may independently test a received trial-order sample or discuss a buyer-designated laboratory for qualified bulk procurement.
Per-batch document pack
Pepti provides a mature COA / HPLC / MS documentation workflow. During RFQ review, the applicable files, selected compound, specification and lot reference are aligned before order confirmation.
| Evidence | What buyers see · Purpose |
|---|---|
| Certificate of Analysis (COA) | Current batch certificate with compound identity, purity/assay fields, lot code and document date for the production lot. Baseline procurement file for B2B research buyer, research organization, regulated pharmacy and OEM buyers. |
| HPLC purity | HPLC chromatogram support checked by compound and batch for the production lot. Purity review before purchase and reorder. |
| MS identity | MS identity confirmation checked by compound and batch for the production lot. Identity confirmation for research and OEM use. |
| Water content | Lyophilized vials report water content (typical ≤4%) on the COA. Stability and storage planning. |
| Lot traceability | Lot reference connected to order file, packaging and batch-linked documents. Reorders cite prior lot for continuity. |
| Packaging proof | Vial label, carton text, insert and lot-code placement reflected before production. OEM and repeat-procurement confidence. |
From inquiry to lot file
Compound class, partner file, format and batch-level traceability checked before quoting.
Every production lot includes a batch-linked COA, HPLC chromatogram and MS identity record checked against the selected compound and lot reference before invoice.
HPLC for purity, MS for identity, water for stability. Chromatograms attached to the lot file.
Batch-linked COA / HPLC / MS files, packaging proof and lot sheet compiled, shipment route confirmed.
Production & QC
Lyophilized peptides are produced under GMP conditions — controlled synthesis, cleanroom fill and HPLC/MS analysis for the production lot before release.
Buyer-controlled verification
independent peptide testing is available; independent third-party testing is available for peptide supplier verification and independent third-party peptide testing can verify peptide supplier before bulk order. For a small first order, buyers can independently test a received sample at a laboratory they trust. For a qualified bulk RFQ, a buyer-designated laboratory, intended-lot sample and analytical panel can be coordinated privately, helping buyers verify peptide supplier before bulk order.
Receive the actual product, review batch-linked COA HPLC MS records, select the sample and send it to an independent laboratory before moving to a larger order.
Align the selected laboratory, test panel, intended lot and commercial order plan before testing begins.
FAQ
Yes. Pepti provides batch-linked COA, HPLC chromatogram and MS identity documentation through its batch-document workflow. The applicable current-lot document set is confirmed during RFQ review.
Yes. Buyers can request a redacted sample COA format or a review of the applicable current-lot document set during RFQ review. Generic or historical COAs are not presented as current-lot documents.
Production lots target ≥99% HPLC purity; the actual lot result is shown in that lot's documents. COA summarizes batch results, HPLC supports purity review, and MS supports identity. HPLC purity alone does not prove fill quantity, sterility, endotoxin or suitability for any use.
Independent third-party testing is available for qualified RFQs. Many buyers start with a sample lot, review batch documents, use independent third-party peptide testing, then scale. Cost and turnaround depend on the assay set.
Compound prefix + lot serial (e.g. BPC-10-2026Q2-A). The full lot-code structure is locked at packaging-proof step for repeat OEM supply.